Baruch Halpert
Chairman at Terragenic International Ltd.
Baruch Halpert active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Terragenic International Ltd. | Chairman | 2017-12-31 | - |
Career history of Baruch Halpert
Former positions of Baruch Halpert
| Companies | Position | Start | End |
|---|---|---|---|
| ENLIVEX THERAPEUTICS LTD. | Director/Board Member | 2016-12-31 | - |
Enlivex Therapeutics Ltd. /Old/
 Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Director/Board Member | 2016-12-31 | - |
Training of Baruch Halpert
| The University of Reading | Graduate Degree |
Statistics
International
| Israel | 3 |
| United Kingdom | 2 |
| Australia | 2 |
Operational
| Director/Board Member | 2 |
| Graduate Degree | 1 |
| Chairman | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ENLIVEX THERAPEUTICS LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Enlivex Therapeutics Ltd. /Old/
Enlivex Therapeutics Ltd. /Old/ Medical SpecialtiesHealth Technology Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn’s disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. The company was founded by Dror Mevorach in 2005 and is headquartered in Jerusalem, Israel. | Health Technology |
| Terragenic International Ltd. |
- Stock Market
- Insiders
- Baruch Halpert
- Experience
